Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Discovery, development and commercialization of transformative therapies for cardio-metabolic diseases45.56M100.00%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
Italy45.56M100.00%